1-20 of 173
Muzaffar H. Qazilbash, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Aimaz Afrough, MD, Leonard C Alsfeld, MD, Ruby Delgado, Uday R. Popat, MD, Partow Kebriaei, MD, Betul Oran, MDMS, Neeraj Saini, MD, Samer A. Srour, MD MS, Chitra Hosing, MD, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Robert Z. Orlowski, MDPhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-141261
Published: 2020
Journal Articles

Outcomes in Patients with AL (Light-Chain) Cardiac Amyloidosis

Jeremy L. Ramdial, MD, Mahmoud R. Gaballa, MD, Taha Al-Juhaishi, MD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Yago Nieto, MD, Chitra Hosing, MD, Uday R. Popat, MD, Regan Murphy, PA-C, Hans C. Lee, MD, Krina K. Patel, MD, Elisabet E. Manasanch, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Gregory P. Kaufman, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–13.
https://doi.org/10.1182/blood-2020-143209
Published: 2020
Journal Articles

Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft Versus Host Disease

Rohtesh S. Mehta, MDMPH,MS, Rima M. Saliba, PhD, Anna Jan, Terri Lynn Shigle, PharmD, Emily Wang, Gabriela Rondon, Yago Nieto, MD, Stefan Ciurea, MD, Betul Oran, MDMS, Jin S. Im, Amanda L. Olson, David Marin, Muzaffar H. Qazilbash, MD, Issa F. Khouri, MD, Paolo Anderlini, Katayoun Rezvani, MD PhD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Amin M. Alousi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-139283
Published: 2020
Journal Articles

Long-Term Survival for Myeloma after Autologous Stem Cell Transplantation

Samer A. Srour, MD MS, Qaiser Bashir, MD, Denái R. Milton, MS, Yago Nieto, MD, Rohtesh S. Mehta, MDMPH,MS, Neeraj Saini, MD, Ruby Delgado, Gabriela Rondon, Stefan O. Ciurea, MD, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Elisabet E. Manasanch, MD, Chitra Hosing, MD, Krina K. Patel, MD, Hans C. Lee, MD, Elizabeth J. Shpall, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-143053
Published: 2020
Journal Articles

Survival Trends in Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation

Samer A. Srour, MD MS, Qaiser Bashir, MD, Denái R. Milton, MS, Yago Nieto, MD, Rohtesh S. Mehta, MDMPH,MS, Neeraj Saini, MD, Ruby Delgado, Gabriela Rondon, Chitra Hosing, MD, Stefan O. Ciurea, MD, May Daher, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Elisabet E. Manasanch, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Elizabeth J. Shpall, MD, Hans C. Lee, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-143196
Published: 2020
Journal Articles

Outcomes of Patients with Multiple Myeloma Who Received VRD Induction, Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance

Mahmoud R. Gaballa, MD, Taha Al-Juhaishi, MD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Yago Nieto, MD, Regan Murphy, PA-C, Hans C. Lee, MD, Krina K. Patel, MD, Partow Kebriaei, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-135865
Published: 2020
Journal Articles

Extensive Changes of the Immune Microenvironment Are Associated with Progression from Precursor Stages to Multiple Myeloma

Elisabet E. Manasanch, MD, Guangchun Han, Zheng Zhang, Minghao Dang, Manisha Singh, Maliha Khan, MD, Shubhra Singh, Hans C. Lee, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Behrang Amini, MD PhD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Yago Nieto, MD, Muzaffar H. Qazilbash, MD, Zuzana Berkova, PhD, Pei Lin, MDDM,MDC, Donald Berry, MD PhD, Sheeba K. Thomas, MD, Donna M. Weber, MD, P. Andrew Futreal, Linghua Wang, PhD, Robert Z. Orlowski, MDPhD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137555
Published: 2020
Journal Articles

Maintenance Use Is More Important Than the Choice of Bortezomib-Based Triplet Induction in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Stem Cell Transplantation

Surbhi Sidana, MD, Shaji K. Kumar, MD, Raphael Fraser, PhD, Noel Estrada-Merly, MS, Maxim Norkin, MD PhD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD, Nina Shah, MD, Anita D'Souza, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-139017
Published: 2020
Journal Articles

Trial in Progress: A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule(s) and Dose(s) of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Qaiser Bashir, MD, Peter F Thall, PhD, Dawen Sui, Cristina Knape, Jitesh Kawedia, BPharm, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-139853
Published: 2020
Journal Articles

Autologous Vs. Allogeneic Stem Cell Transplantation in Double-Expressor Lymphoma

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Celina Ledesma, Paolo Anderlini, Qaiser Bashir, May Daher, Swami P. Iyer, MD, David Marin, Rohtesh Mehta, Amanda L. Olson, Uday R. Popat, MD, Felipe Samaniego, MD, Muzaffar H. Qazilbash, MD, Jin S. Im, Gabriela Rondon, Richard E. Champlin, MD, Alison Gulbis, Ken H. Young
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-138741
Published: 2020
Journal Articles

Autologous Stem Cell Transplantation for Angioimmunoblastic T-Cell Lymphoma

Samer A. Srour, MD MS, Yago Nieto, MD, Swaminathan P Iyer, MD, Roberto N. Miranda, MD, Farzaneh Maadani, Gabriela Rondon, Neeraj Saini, MD, Paolo Strati, MD, May Daher, Ranjit Nair, MD, Bouthaina S. Dabaja, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Elizabeth J. Shpall, MD, Christopher Flowers, MDMS, Richard E. Champlin, MD, Chitra Hosing, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-142889
Published: 2020
Journal Articles

High-Dose Chemotherapy (HDC) with Autologous Stem-Cell Transplant (ASCT) with Consolidative Radiation Therapy (RT) for Relapsed or Refractory (R/R) Primary Mediastinal B-Cell Lymphoma (PMBCL): 20-Year Experience at MD Anderson Cancer Center (MDACC)

Neeraj Saini, MD, Junsheng Ma, MS, Melissa Timmons, PA-C, Amin M. Alousi, MD, Paolo Anderlini, Borje S. Andersson, MD, PhD, Chitra Hosing, MD, Jeremy Ramdial, MD, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Elizabeth J. Shpall, MD, Samer A. Srour, MD MS, Benigno C. Valdez, PhD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Yago Nieto, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-134471
Published: 2020
Journal Articles

Results of a Phase 1 Open Label Dose Escalation Trial of AB-205 (Allogeneic Engineered Endothelial Cell Therapy) in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT)

Michael Scordo, MD, Lihua E Budde, MD PhD, Mehrdad Abedi, MD, Carolyn Mulroney, MD, Bita Fakhri, MDMPH, Attaphol Pawarode, MDPhD, Bhagirathbhai Dholaria, MBBS, Edward Kavalerchik, MD, Sanjay K. Aggarwal, MD, Muzaffar H. Qazilbash, MD, Paul Finnegan, MD, Sergio A. Giralt, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-137257
Published: 2020
Journal Articles

Phase 2 Study of Tagraxofusp Therapy for BPDCN Patients Post-Autologous or Post-Allogeneic Hematopoietic Cell Transplantation

Qaiser Bashir, MD, Katayoun Rezvani, MD PhD, Neeraj Saini, MD, Elizabeth J. Shpall, MD, Samer A. Srour, MD MS, Uday R. Popat, MD, Denái R. Milton, MS, Naveen Pemmaraju, MD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-137207
Published: 2020
Journal Articles

Prognostic Impact of Beta 2 Microglobulin in Patients with Immunoglobulin Light-Chain Amyloidosis Undergoing Autologous Hematopoietic Stem Cell Transplantation

Aimaz Afrough, MD, Samer A. Srour, MD MS, Qaiser Bashir, MD, Neeraj Saini, MD, Chitra Hosing, MD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Ruby Delgado, Regan Murphy, PA-C, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-141360
Published: 2020
Journal Articles

Update of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)

Sheeba K. Thomas, MD, Jatin J. Shah, MD, Armando Morin, M.A., Ashley N. Morphey, M.S.N., Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Swami P. Iyer, MD, Lei Feng, MS, Behrang Amini, MD PhD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Ralph J. Johnson, PhD, Brandon N. Crumpton, Mildred D. Stafford, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-139934
Published: 2020
Journal Articles

African-Americans Multiple-Myeloma Patients Undergoing Upfront Autologous Stem Cell Transplant Have Similar Survival Outcomes Compared to Whites: A Propensity-Score Matched Analysis

Neeraj Saini, MD, Junsheng Ma, MS, Qaiser Bashir, MD, Ruby Delgado, Gabriela Rondon, Uday R. Popat, MD, Chitra Hosing, MD, Yago Nieto, MD, Partow Kebriaei, MD, Amin M. Alousi, MD, Rohtesh S. Mehta, MDMPH,MS, Samer A. Srour, MD MS, Issa F. Khouri, MD, Donna M. Weber, MD, Sheeba K. Thomas, MD, Hans C. Lee, MD, Krina K. Patel, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-134837
Published: 2020
Journal Articles

Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience

Yago Nieto, MD, Stephen K. Gruschkus, PhD MPH, Roy B. Jones, MD PhD, Benigno C. Valdez, PhD, Melissa Timmons, PA-C, Chitra Hosing, MD, Paolo Anderlini, Partow Kebriaei, MD, Uday R. Popat, MD, Muzaffar H. Qazilbash, MD, Amin M. Alousi, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Jin S. Im, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD PhD, Alison Gulbis, Terri Lynn Shigle, PharmD, Kris Michael Mahadeo, MD, Sajad Khazal, MD, Issa F. Khouri, MD, Bouthaina S. Dabaja, MD, Chelsea C. Pinnix, MD PhD, Jillian R. Gunther, MD PhD, Hun Lee, MD, Sairah Ahmed, MD, Raphael Eric Steiner, MD, Swaminathan P Iyer, MD, Ranjit Nair, MD, Simrit Parmar, MD, MSCI, Branko Cuglievan, MD, Farzaneh Maadani, BS, MT, Gabriela Rondon, Richard E. Champlin, MD, Borje S. Andersson, MD, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-139880
Published: 2020
Journal Articles

Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with t(11;14) Undergoing Autologous Hematopoietic Stem Cell Transplantation

Aimaz Afrough, MD, Leonard C Alsfeld, MD, Samer A. Srour, MD MS, Qaiser Bashir, MD, Neeraj Saini, MD, Chitra Hosing, MD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Ruby Delgado, Regan Murphy, PA-C, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-141307
Published: 2020
Journal Articles

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Rohtesh S. Mehta, MDMPH,MS, Roland Bassett, Julianne Chen, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Amin M. Alousi, MD, Gheath Alatrash, Qaiser Bashir, MD, Stefan Ciurea, MD, Chitra Hosing, MD, Jin S. Im, Partow Kebriaei, MD, Amanda L. Olson, Betul Oran, MDMS, Muzaffar H. Qazilbash, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Borje S. Andersson, MD, PhD, Richard E. Champlin, MD, Uday R. Popat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-139325
Published: 2020